Pharmagrex SA
The score of Pharmagrex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmagrex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Sep 2026
- Year ended 31 Dec 2024filed on 04 Sep 2025
- Year ended 31 Dec 2023filed on 17 Dec 2024
- Year ended 31 Dec 2022filed on 18 Dec 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Pharmagrex's financial analysis
- Solvency87.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmagrex
Pharmagrex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0635.846.678
- VAT number
- BE0635846678
- Peppol
- Registered · 0208:0635846678 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Aug 2015
- Registered office
- 2850 Boom
- Latest accounts
- 2025 · filed on 23 Sep 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmagrex (SA) has been based in Boom since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 284,105 € and equity of €1.31m; its revenue is not published. Its solvency stands at 87.3%, above the median of its sector (55.6%).
Companies similar to Pharmagrex
Companies in the same business, of comparable size and area, outside its group.
- Eurorent - Brussels Activities of holding companies Uccle · balance sheet €1.50m
- VML Group Activities of holding companies Ghent · balance sheet €1.50m
- Bakimmo Activities of holding companies Londerzeel · balance sheet €1.49m
- finexperience Activities of holding companies Nijlen · balance sheet €1.51m
- Erasmus Dental Activities of holding companies Kortrijk · balance sheet €1.49m
- UDE Activities of holding companies Liège · balance sheet €1.49m
- CG Vasbinder Activities of holding companies Chaudfontaine · balance sheet €1.51m
- VP'S Development Activities of holding companies Rixensart · balance sheet €1.48m
Frequently asked questions about Pharmagrex
What is the revenue of Pharmagrex?
Pharmagrex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmagrex?
In Belgium, the VAT number is the company number prefixed with BE: BE0635846678 for Pharmagrex, if the company is VAT-registered. Its company number (CBE) is 0635.846.678.
Where is the registered office of Pharmagrex?
According to the CBE register, the registered office of Pharmagrex is in 2850 Boom.
What is the equity of Pharmagrex?
At the close of the 2025 financial year, the equity of Pharmagrex amounts to 1,307,483 €, a solvency of 87.3% of total assets.
Who manages Pharmagrex?
The register lists 3 active mandates at Pharmagrex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmagrex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →